John J. Savarese, M.D.
Managing Director

Dr. Savarese is a Managing Director at Montreux Equity Partners. Prior to joining Montreux, Dr. Savarese served as Director of Business Development and Marketing with the entrepreneurial team at NeurogesX (NASDAQ: NGSX), a Montreux portfolio company focused on the treatment of pain. Dr. Savarese worked in the Life Sciences Investment Banking division at Credit Suisse First Boston and started his career in the venture industry as a consultant to private equity firms and early stage companies.

Dr. Savarese’s clinical experience in General and Orthopedic Surgery was gained at the Cornell University Medical College/Hospital for Special Surgery. Dr. Savarese received his M.B.A. from the Stanford University. Dr. Savarese is a board director or observer for Montreux portfolio companies, KFx, Verus, Avantis Medical, Bayhill and Novalar. In addition, he was actively involved in Montreux’s investment decisions in Somaxon (NASDAQ: SOMX), Aryx (NASDAQ: ARYX), Orexigen (NASDAQ: OREX), Cerexa (Forest labs), Renal CarePartners, NovoStent and Asthmatx.